| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 34 |
| 1 | OMEPRAZOLE MAGNESIUM | 14 |
| 2 | BEVACIZUMAB | 13 |
| 3 | NAPROXEN SODIUM | 13 |
| 4 | AZATHIOPRINE | 12 |
| 5 | MYCOPHENOLATE MOFETIL | 12 |
| 6 | DAPRODUSTAT | 11 |
| 7 | OMEPRAZOLE | 11 |
| 8 | PREDNISOLONE | 11 |
| 9 | PREDNISOLONE ORAL | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VELMANASE ALFA-TYCV | 1 | 0.0179 |
| 1 | DAPRODUSTAT | 11 | 0.0055 |
| 2 | EDARAVONE | 6 | 0.0037 |
| 3 | LONCASTUXIMAB TESIRINE | 1 | 0.0024 |
| 4 | CEFPODOXIME PROXETIL | 2 | 0.0020 |
| 5 | SMOFLIPID | 1 | 0.0011 |
| 6 | NIROGACESTAT | 1 | 0.0011 |
| 7 | DANTROLENE SODIUM | 1 | 0.0009 |
| 8 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 9 | DESMOPRESSIN ACETATE | 3 | 0.0008 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 11 | 0.0048 |
| 1 | Gamma Secretase Inhibitor [EPC] | 1 | 0.0011 |
| 2 | Chloride Channel Activator [EPC] | 5 | 0.0005 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 9 | 0.0004 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 6 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 7 | GLP-2 Analog [EPC] | 5 | 0.0004 |
| 8 | Cannabinoid [EPC] | 3 | 0.0004 |
| 9 | Melatonin Receptor Agonist [EPC] | 3 | 0.0002 |